Laura K. Ferris
Expertise in
9
conditions

Dr. Laura K. Ferris

University Of Pittsburgh Physicians
Pittsburgh, PA
Expertise in
9
conditions
Specialties:Dermatology | Pediatrics | General Practice
Expertise in
9
conditions
OverviewInsuranceLocationsClinical Research

Overview

Laura Ferris is a Dermatologist and an Internal Medicine provider in Pittsburgh, Pennsylvania. Dr. Ferris is highly rated in 9 conditions, according to our data. Her top areas of expertise are Psoriasis, Plaque Psoriasis, Melanoma, and Familial Atypical Multiple Mole Melanoma Syndrome.

Her clinical research consists of co-authoring 128 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Pediatrics
General Practice
Licenses
Specialist in PA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc St Margaret
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

UNIVERSITY OF PITTSBURGH PHYSICIANS
815 Freeport Rd, Pittsburgh, PA 15215
412-383-3200
Other Locations
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
410 Market St, Suite 400a, Chapel Hill, NC 27516
984-974-3900
UNIVERSITY OF PITTSBURGH PHYSICIANS
200 Lothrop St, Pittsburgh, PA 15213

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis
A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis
Enrollment Status: Terminated
Publish Date: March 15, 2022
Intervention Type: Drug
Study Drugs: LY3462817-IV, LY3462817-SV
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

128 Total Publications

Total body skin examination visits by dermatology providers in the 2011-2016 National Ambulatory Medical Care Survey.
Total body skin examination visits by dermatology providers in the 2011-2016 National Ambulatory Medical Care Survey.
Journal: Melanoma research
Published: October 31, 2024
Similar Doctors
Oleg E. Akilov
Expertise in
8
conditions
Dr. Oleg E. Akilov
Dermatology
Expertise in
8
conditions
Dr. Oleg E. Akilov
Dermatology

University Of Pittsburgh Physicians

5230 Centre Ave, 
Pittsburgh, PA 
 (3.2 mi)
412-623-2047
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Oleg Akilov is a Dermatologist in Pittsburgh, Pennsylvania. Dr. Akilov is highly rated in 8 conditions, according to our data. His top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Sezary Syndrome, and T-Cell Lymphoma.

Expertise in
3
conditions
Dr. Orin M. Goldblum
Dermatology
Expertise in
3
conditions
Dr. Orin M. Goldblum
Dermatology
256 Merion Dr, 
Pittsburgh, PA 
 (10.5 mi)
412-343-3636
Languages Spoken:
English

Orin Goldblum is a Dermatologist in Pittsburgh, Pennsylvania. Dr. Goldblum is highly rated in 3 conditions, according to our data. His top areas of expertise are Psoriasis, Plaque Psoriasis, and Atopic Dermatitis.

Expertise in
6
conditions
Dr. Uta Lichter-Konecki
Pediatrics | Medical Genetics
Expertise in
6
conditions
Dr. Uta Lichter-Konecki
Pediatrics | Medical Genetics

University Of Pittsburgh Physicians

4401 Penn Ave, 
Pittsburgh, PA 
 (3.3 mi)
412-692-5520
Languages Spoken:
English
See accepted insurances

Uta Lichter-Konecki is a Pediatrics specialist and a Medical Genetics provider in Pittsburgh, Pennsylvania. Dr. Lichter-Konecki is highly rated in 6 conditions, according to our data. Her top areas of expertise are Urea Cycle Disorders (UCD), Phenylketonuria (PKU), Maple Syrup Urine Disease, and Inborn Amino Acid Metabolism Disorder.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile